Dr. Amy Bergerson
University of Utah
The Research Institute is designed for NASPA members who are administrators, students, and faculty. The Institute’s theme centers on the role of data in creating social change.
Participants will work with a number of researchers from higher education to refine their research interests, consider how to make time to conduct research, learn about ways to fund research, and explore publishing outlets. Interactive panels, roundtables, and breakout sessions will allow participants to tailor the Institute to their interests and needs, and each participant will leave the Institute with next steps for achieving their research-related goals.
This event is most likely to influence these groups.
Let others know you are coming!
The 2016 NASPA Western Regional Conference will be held at the iconic Westin Seattle hotel, located in the Emerald City's Cultural Core. Centrally located within walking distance of Pike Place Market, the Monorail, and the Space Needle, the hotel is ideally located for the NASPA WRC and will allow attendees an opportunity to discover and experience all that Seattle has to offer. Hotel reservations are now open.
Book your room today!
Please note that the rate for a Quad will incorrectly show $239 on the reservation site. Your confirmation should reflect the $209 rate after booking.
The Westin Seattle
1900 5th Avenue, Seattle, WA 98101
$179 - Single/Double
$209 - Triple/Quad
Steven E. Kern, PhD is Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation. The Quantitative Sciences group is focused on quantitative analysis to support program strategies for therapeutic projects that the foundation funds.
Prior to this, he was Global Head of Pharmacology Modeling at Novartis Pharma AG based in Basel Switzerland where he lead a team focused on providing model based drug development support to therapeutics in many disease conditions across all stages of drug development. He joined Novartis in 2010 from the University of Utah in Salt Lake City, Utah where he was Associate Professor of Pharmaceutics, Anesthesiology, and Bioengineering, and served as co-investigator for their NIH funded Pediatric Pharmacology Research Unit. He has designed, conducted, and served as a principal investigator for clinical pharmacology studies in adults and children that spanned the population from preterm infants to elderly adults.
He has a bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Bioengineering from Penn State University, and a doctoral degree in Bioengineering from the University of Utah. Dr. Kern has published over 70 papers in areas of pharmacokinetic and pharmacodynamic modeling, applying principles of control systems engineering to drug delivery, and clinical pharmacology.